(2006). Association between tPA therapy and raised early matrix metalloproteinase-9 in acute stroke. Neurology
(2006). Atorvastatin downregulates tissue plasminogen activator-aggravated genes mediating coagulation and vascular permeability in single cerebral endothelial cells captured by laser microdissection. J Cereb Blood Flow Metab
(2003). Bordet R: Involvement of thrombolysis in recombinant tissue plasminogen activator-induced cerebral hemorrhages and effect on infarct volume and postischemic endothelial function. Stroke
(2008). et al.: Synergistic effect of an endothelin type A receptor antagonist, S-with rtPA on the neuroprotection after embolic stroke. Stroke
(2006). Florquin S: Tissue-type plasminogen activator modulates inflammatory responses and renal function in ischemia reperfusion injury.
(2001). FR: Blood genomic responses differ after stroke, seizures, hypoglycemia, and hypoxia: blood genomic fingerprints of disease. Ann Neurol
(2006). FR: Genomic profiles for human peripheral blood T cells, B cells, natural killer cells, monocytes, and polymorphonuclear cells: comparisons to ischemic stroke, migraine, and Tourette syndrome. Genomics
(2007). GA: Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat.
(2006). Gene expression in blood changes rapidly in neutrophils and monocytes after ischemic stroke in humans: a microarray study. J Cereb Blood Flow Metab
(2008). Gene expression in peripheral blood differs after cardioembolic compared with large-vessel atherosclerotic stroke: biomarkers for the etiology of ischemic stroke.
Lindsberg PJ: An emerging role of mast cells in cerebral ischemia and hemorrhage.
(2007). Lindsberg PJ: Mast cell stabilization reduces hemorrhage formation and mortality after administration of thrombolytics in experimental ischemic stroke. Circulation
(2003). Lo EH: Lipoprotein receptormediated induction of matrix metalloproteinase by tissue plasminogen activator. Nat Med
(2004). Lo EH: Mechanisms of hemorrhagic transformation after tissue plasminogen activator reperfusion therapy for ischemic stroke. Stroke
(2009). Neutrophils contribute to intracerebral haemorrhages after treatment with recombinant tissue plasminogen activator following cerebral ischaemia.
(2008). Nighoghossian N: Intracerebral haemorrhage after thrombolysis for acute ischaemic stroke: an update.
(2002). Pre-validation and inference in microarrays. Stat Appl Genet Mol Biol
(2007). Raghubir R: Molecular targets in cerebral ischemia for developing novel therapeutics. Brain Res Rev
(2009). Recanalization and reperfusion therapies for acute ischemic stroke. Cerebrovasc Dis
(1989). Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke
(1999). SC: Effects of citicoline combined with thrombolytic therapy in a rat embolic stroke model. Stroke